Targeting Alpha-Synuclein: Breakthroughs in the Quest to Halt Parkinson's Progression

By A Mystery Man Writer
Last updated 21 Sept 2024
Targeting Alpha-Synuclein: Breakthroughs in the Quest to Halt Parkinson's  Progression
The quest for a disease-modifying drug for Parkinson's disease continues - Drug Discovery and Development
PDF] Therapeutic approaches to target alpha-synuclein pathology
The Odyssey of Alpha-synuclein and Neuroinflammatory Mediators as Potential Candidates in the Aetiology of Parkinson's Disease
IJMS, Free Full-Text
The Odyssey of Alpha-synuclein and Neuroinflammatory Mediators as Potential Candidates in the Aetiology of Parkinson's Disease
Rethinking Parkinson's Disease Treatment: The Shift Towards Multifaceted Approaches
Pharmaceutics, Free Full-Text
New hopes for disease modification in Parkinson's Disease - ScienceDirect
Alpha-Synuclein: Biomarker for Parkinson's Disease, It's Estimation Methods, and Targeted Medicinal Therapies
IJMS, Free Full-Text
Biomolecules, Free Full-Text

© 2014-2024 thehygienecleaningcompany.com.au. Inc. or its affiliates.